Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Staels

Showing results (271-280 of 594) with videos related to

Pageof 60
Sort By:
Journal of Cardiovascular Pharmacology|June 20, 2007
The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathyFrançois Brigadeau, Patrick Gelé, Maud Wibaux, et al.
European Heart Journal|July 31, 2012
Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein productionSophie Colin, Olivier Briand, Véronique Touche, et al.
Diabetologia|January 28, 2014
Alternative human liver transcripts of TCF7L2 bind to the gluconeogenesis regulator HNF4α at the protein levelBernadette Neve, Olivier Le Bacquer, Sandrine Caron, et al.
Biochemical Pharmacology|December 31, 2002
Inhibition of cytokine production by the herbicide atrazine. Search for nuclear receptor targetsSabrina Devos, Karolien De Bosscher, Bart Staels, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2004
Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic miceJanice M Paterson, Nicholas M Morton, Catherine Fievet, et al.
Atherosclerosis|April 26, 2016
The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosisNathalie Hennuyer, Isabelle Duplan, Charlotte Paquet, et al.
Journal of Hepatology|February 13, 2025
Unveiling the molecular legacy of transient insulin resistance: Implications for hepatic metabolic adaptabilityAlexandre Berthier, Céline Gheeraert, Manjula Vinod, et al.
Acta Diabetologica|February 23, 2020
Differential unfolded protein response in skeletal muscle from non-diabetic glucose tolerant or intolerant patients with obesity before and after bariatric surgeryCamille Marciniak, Christian Duhem, Alexis Boulinguiez, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 26, 2010
Telomerase activation in atherosclerosis and induction of telomerase reverse transcriptase expression by inflammatory stimuli in macrophagesFlorence Gizard, Elizabeth B Heywood, Hannes M Findeisen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 22, 2011
Overweight induced by chronic risperidone exposure is correlated with overexpression of the SREBP-1c and FAS genes in mouse liverEmilie Lauressergues, Françoise Martin, Audrey Helleboid, et al.
Pageof 60

Showing results (271-280 of 594) with videos related to

Sort By:
Pageof 60
Journal of Cardiovascular Pharmacology|June 20, 2007
The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathyFrançois Brigadeau, Patrick Gelé, Maud Wibaux, et al.
European Heart Journal|July 31, 2012
Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein productionSophie Colin, Olivier Briand, Véronique Touche, et al.
Diabetologia|January 28, 2014
Alternative human liver transcripts of TCF7L2 bind to the gluconeogenesis regulator HNF4α at the protein levelBernadette Neve, Olivier Le Bacquer, Sandrine Caron, et al.
Biochemical Pharmacology|December 31, 2002
Inhibition of cytokine production by the herbicide atrazine. Search for nuclear receptor targetsSabrina Devos, Karolien De Bosscher, Bart Staels, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2004
Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic miceJanice M Paterson, Nicholas M Morton, Catherine Fievet, et al.
Atherosclerosis|April 26, 2016
The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosisNathalie Hennuyer, Isabelle Duplan, Charlotte Paquet, et al.
Journal of Hepatology|February 13, 2025
Unveiling the molecular legacy of transient insulin resistance: Implications for hepatic metabolic adaptabilityAlexandre Berthier, Céline Gheeraert, Manjula Vinod, et al.
Acta Diabetologica|February 23, 2020
Differential unfolded protein response in skeletal muscle from non-diabetic glucose tolerant or intolerant patients with obesity before and after bariatric surgeryCamille Marciniak, Christian Duhem, Alexis Boulinguiez, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 26, 2010
Telomerase activation in atherosclerosis and induction of telomerase reverse transcriptase expression by inflammatory stimuli in macrophagesFlorence Gizard, Elizabeth B Heywood, Hannes M Findeisen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 22, 2011
Overweight induced by chronic risperidone exposure is correlated with overexpression of the SREBP-1c and FAS genes in mouse liverEmilie Lauressergues, Françoise Martin, Audrey Helleboid, et al.
Pageof 60